USBC - USBC Inc. Debt to Book Capitalization Ratio

USBC Inc (USBC) is investing in non-invasive glucose monitoring systems, with its market valuation currently captured at 0.31. Long-term agreements with chip suppliers guarantee the stability of component deliveries. The development of a unique painless sensor will provide the holding company with dominant pricing power in the diabetes market. The brand is currently building its image, while shareholder confidence remains speculative until regulatory reviews are completed.

This indicator measures the degree of business reliance on borrowed funds relative to equity, allowing for an assessment of insolvency risk and the cost of servicing obligations. By analyzing the trend of the debt-to-equity ratio, an investor can gauge the stability of USBC Inc. during the Bio-RFID development stage, where minimizing the debt load is critical prior to transitioning to high-margin technology licensing.